BioTech/Drugs - South San Francisco, California, US
UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.
Outlook
Drupal
Freshdesk
Microsoft Office 365
CloudFlare Hosting
Adobe Marketing Cloud